Alcohol and Drug Abuse Research Center
Neuroimaging Center
Clinical Unit Based Research
Alcohol and Drug Abuse Treatment Program
Clinical Psychopharmacology Research Program
Cognitive Neuroscience Laboratory
Developmental Biopsychiatry Research Program
Developmental Psychology and Psychopathology Programs
Eating Disorders Education and Prevention
Geriatric Psychiatry Research Program
Laboratory for the Study of Adult Development
Nursing Research
Personality and Psychosocial Research Program
Psychopharmacology Research Laboratory
Schizophrenia and Bipolar Disorder Program
Mailman Research Center
Shervert H. Frazier Research Institute
Clinical Trials
Inventions for License
Research News
Research Update 2006-2007
Research Overview
Administration

CLINICAL UNIT BASED RESEARCH

Psychopharmacology Research Laboratory

Andrew Stoll

Dr. Andrew Stoll, MD

Clinician-investigators in the Psychopharmacology Research Laboratory, directed by Andrew Stoll, M.D., are conducting research on naturally occurring compounds whose properties suggest that they may ameliorate the symptoms of bipolar disorder.

These include omega-3 fatty acids (a constituent of fish oil), taurine and SAMe. Preliminary findings include the discovery that omega-3 fatty acids, unlike most substances, cross the blood brain barrier into the human brain and cause a change in membrane physiology. These naturally occurring products represent entirely new ways to treat illness that may be safer, and more effective than current approaches.